Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ádám Jánoska"'
Autor:
Gergő Tóth, Ádám Jánoska, Gergely Völgyi, Zoltán-István Szabó, Gábor Orgován, Arash Mirzahosseini, Béla Noszál
Publikováno v:
Journal of Chemistry, Vol 2017 (2017)
Lapatinib (LAP), the tyrosine kinase inhibitor drug with moderate bioavailability, was characterized in terms of physicochemical properties: acid-base characteristics, lipophilicity, and solubility. The highly lipophilic nature of the drug and its ex
Externí odkaz:
https://doaj.org/article/b68c880b4096497a98854c98d6e6fbbd
Autor:
Zoltán-István Szabó, Gábor Orgován, Gergő Tóth, Ádám Jánoska, Gergely Völgyi, Arash Mirzahosseini, Béla Noszál
Publikováno v:
Journal of Chemistry, Vol 2017 (2017)
Lapatinib (LAP), the tyrosine kinase inhibitor drug with moderate bioavailability, was characterized in terms of physicochemical properties: acid-base characteristics, lipophilicity, and solubility. The highly lipophilic nature of the drug and its ex
Autor:
Gergő Tóth, Balázs Komjáti, Ádám Jánoska, Daniela Lucia Muntean, Peter Horvath, Zoltán-István Szabó, József Nagy, Béla Noszál, Levente Szőcs
Publikováno v:
Journal of separation science. 39(15)
A sensitive and validated liquid chromatography with mass spectrometry method was developed for the enantioseparation of the racemic mixture of pomalidomide, a novel, second-generation immunomodulatory drug, using β-cyclodextrin-bonded stationary ph
Autor:
Gergely Völgyi, Lajos Szente, Ádám Jánoska, Béla Noszál, Gábor Orgován, Gergő Tóth, Zoltán-István Szabó
Erlotinib (ERL), the anticancer drug of poor bioavailability, was quantified in terms of bio-relevant physicochemical parameters, such as acid–base properties, lipophilicity and solubility, and a comprehensive study on its inclusion complexation wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::385e7ca8b12865aac45cff28b306afc4